South African Medical Research Council/National Health Laboratory Services/University of Cape Town Molecular Mycobacteriology Research Unit & Department of Science and Innovation, National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Department of Pathology.
Institute of Infectious Diseases and Molecular Medicine.
Am J Respir Crit Care Med. 2022 Jul 15;206(2):206-216. doi: 10.1164/rccm.202110-2378OC.
Interrupting tuberculosis (TB) transmission requires an improved understanding of how and when the causative organism, (), is aerosolized. Although cough is commonly assumed to be the dominant source of aerosols, recent evidence of cough-independent release implies the contribution of alternative mechanisms. To compare the aerosolization of bacilli and total particulate matter from patients with TB during three separate respiratory maneuvers: tidal breathing (TiBr), FVC, and cough. Bioaerosol sampling and enumeration by live-cell, fluorescence microscopy were combined with real-time measurement of CO concentration and total particle counts from 38 patients with GeneXpert-positive TB before treatment initiation. For all maneuvers, the proportions of particles detected across five size categories were similar, with most particles falling between 0.5-5 μm. Although total particle counts were 4.8-fold greater in cough samples than either TiBr or FVC, all three maneuvers returned similar rates of positivity for . No correlation was observed between total particle production and count. Instead, for total counts, the variability between individuals was greater than the variability between sampling maneuvers. Finally, when modelled using 24-hour breath and cough frequencies, our data indicate that TiBr might contribute more than 90% of the daily aerosolized among symptomatic patients with TB. Assuming the number of viable organisms released offers a reliable proxy of patient infectiousness, our observations imply that TiBr and interindividual variability in release might be significant contributors to TB transmission among active cases.
中断结核病(TB)传播需要更好地了解病原体()何时以及如何气溶胶化。虽然咳嗽通常被认为是气溶胶的主要来源,但最近发现的与咳嗽无关的释放证据表明存在替代机制。本研究旨在比较 38 例未经治疗的 GeneXpert 阳性肺结核患者在三种不同呼吸动作(平静呼吸(TiBr)、用力肺活量(FVC)和咳嗽)期间 杆菌和总颗粒物的气溶胶化。通过活细胞荧光显微镜对生物气溶胶进行采样和计数,并结合 CO 浓度和总颗粒物计数的实时测量。对于所有动作,五个粒径范围内检测到的颗粒比例相似,大多数颗粒落在 0.5-5 μm 之间。尽管咳嗽样本中的总颗粒物计数比 TiBr 或 FVC 高 4.8 倍,但所有三种动作对 的阳性率相似。总颗粒物产生与 计数之间未观察到相关性。相反,对于总 计数,个体之间的变异性大于采样动作之间的变异性。最后,当使用 24 小时呼吸和咳嗽频率进行建模时,我们的数据表明,在有症状的肺结核患者中,TiBr 可能贡献了超过 90%的日常气溶胶化 。假设释放的活 数量提供了患者传染性的可靠指标,我们的观察结果表明,TiBr 和 释放的个体间变异性可能是活动性病例中 TB 传播的重要因素。